Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0725
Bid: 0.07
Ask: 0.075
Change: -0.0075 (-9.38%)
Spread: 0.005 (7.143%)
Open: 0.08
High: 0.08
Low: 0.0725
Prev. Close: 0.08
RBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Formation of new division

5 Dec 2007 07:01

Adventis Group PLC05 December 2007 For release 7.00am 5th December 2007 Adventis Group plc (ATG/L) "Formation of New Market-Leading Healthcare Services Provider - Adventis Health Limited" Adventis Group plc ("Adventis" or the "Company"), the AIM-quoted full servicemultimedia marketing and advertising agency, announces that it has recentlyconsolidated its three healthcare creative and medical education agencies, whichformed the Adventis Healthcare services division, namely Affiniti Advertising,Roundhouse HealthAd and LeapFrog, into a new trading entity which will bebranded Adventis Health Limited ("Adventis Health"). Adventis Health will be run by three directors, namely Stuart Tennant, TimSchofield and Kevin McGetrick. All three have extensive healthcare andmanagement experience. This consolidation of Adventis Group's strength in the healthcare sector followson from the former division's earlier move into centralised premises inBeaconsfield, near to the M25 and M40, in August 2007 in addition to theCompany's existing offices in Hertford and Central London. Adventis Health, whose clients include, GSK, Pfizer, MSD, Roche, Novartis,Boehringer Ingelheim, Allergan, Baxter and Merck Serono, provides a range ofhighly skilled advertising and marketing services as well as medical education &PR programmes to the healthcare industry, targeted at both healthcareprofessionals and patients, in order to improve clients' sales and brandawareness. The Company anticipates that the formation of Adventis Health will create one ofthe industry's top five pharmaceutical industry service providers with aformidable, award-winning team of over 60 employees. The enlarged Healthcareservices operations will have the capability to provide a complete range ofintegrated marketing services, from medical education, to advertising, to newmedia. It will also provide the opportunity for an increased level ofcross-selling and the ability to provide multinational clients with a greaterlocal understanding of target markets. Charles Phillpot, Chief Executive of Adventis Group plc, commented: "The creation of this new platform servicing the healthcare sector is afantastic opportunity to leverage to the full our expertise in this arena. Wewill now be one of the few companies in the industry to offer a full servicemarketing capability and the ability to handle larger and more complex campaignsfor clients." -ENDS- Enquiries: Adventis Group PlcCharles Phillpot, CEO Tel: 020 7034 4750Peter Linnell, Finance Director Tel: 020 7034 4795 Adventis Financial PRChris Steele Tel: 020 7034 4759Tarquin Edwards Tel: 020 7034 4758 Editor's Note: Adventis Group plc provides a complete range of communications services,including corporate identity programmes, advertising campaigns, media andplanning and buying, literature, public relations, packaging, exhibitions,research and planning, interiors signage and digital media. The group employsc.150 staff in London and the southeast. Adventis has three divisions focusing on providing a range of services to theproperty, healthcare and financial sectors. Adventis Group was admitted to AIMin 2004. www.adventis.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Sep 20187:00 amRNSDanube Petroleum Investment Update
21st Sep 20189:35 amRNSAndalas Farm-in to Colter
20th Sep 20187:51 amRNSReplacement: Update on Reabold California
20th Sep 20187:00 amRNSUpdate on Reabold California
18th Sep 20187:00 amRNSInvestor Evening Presentation
17th Sep 20187:01 amRNSOperational Update on Wick
17th Sep 20187:00 amRNSAppointment of Nomad and Board Changes
13th Sep 20187:00 amRNSHolding(s) in Company
6th Sep 20182:26 pmRNSHolding(s) in Company
5th Sep 20183:34 pmRNSReplacement: Placing to raise £4.8 million
5th Sep 20181:26 pmRNSPlacing to raise £4.8 million
30th Aug 20187:00 amRNSUpdate on California - Discovery at VG-3 Well
28th Aug 201811:00 amRNSUpdate on Reabold California
20th Aug 20187:00 amRNSUpdate on Reabold California
16th Aug 20189:13 amRNSParta Information Memorandum
13th Aug 20187:00 amRNSUpdate on Reabold California
2nd Aug 20181:08 pmRNSHolding(s) in Company
30th Jul 20187:00 amRNSUpdate on Reabold California
25th Jul 20188:22 amRNSUpdate on Colter and Wick Projects
11th Jul 20189:58 amRNSParta - Independent Evaluation Results
5th Jul 20185:09 pmRNSHolding(s) in Company
29th Jun 201812:56 pmRNSResult of GM, and Acquisition of Gaelic Resources
29th Jun 20187:00 amRNSAnnual Report and Financial Statements 2017
22nd Jun 20184:44 pmRNSGeneral Meeting
15th Jun 201810:10 amRNSCompany Presentation
14th Jun 20187:00 amRNSAcquisition of Gaelic Resources and Notice of GM
4th Jun 20187:00 amRNSCPR on Corallian owned Oulton Appraisal Project
30th May 201812:38 pmRNSFinal tranche of investment in Corallian Energy
29th May 20182:02 pmRNSHolding(s) in Company
23rd May 20183:56 pmRNSCorallian 30th Seaward Licensing Round Award
15th May 20187:00 amRNSUpdate on Colter and Wick Projects
3rd Apr 20185:03 pmRNSTotal Voting Rights
3rd Apr 20183:35 pmRNSHolding(s) in Company
28th Mar 20189:46 amRNSFirst tranche of investment in Danube Petroleum
27th Mar 20183:45 pmRNSHolding(s) in Company
22nd Mar 201812:49 pmRNSHolding(s) in Company
21st Mar 20185:13 pmRNSHolding(s) in Company
19th Mar 20181:13 pmRNSResult of General Meeting, Issue of Equity, TVR
14th Mar 20184:24 pmRNSIssue of Options
2nd Mar 20186:04 pmRNSPosting of Circular
1st Mar 201811:30 amRNSIncreased Investment in Corallian Energy
28th Feb 20185:11 pmRNSResult of the Placing
28th Feb 201811:26 amRNSConditional Accelerated Bookbuild
27th Feb 201812:30 pmRNSCompany Update regarding the P2235 "Wick" Licence
26th Feb 20181:24 pmRNSStatement re Press Comment
12th Feb 20189:49 amRNSIntention to increase Corallian Energy investment
24th Jan 20185:20 pmRNSHolding(s) in Company
16th Jan 201811:16 amRNSUpdate on UK oil and gas assets
4th Dec 20177:00 amRNSInvestment in Danube Petroleum Limited
14th Nov 20177:00 amRNSPresentation at Investor Evening

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.